Market Statistics
Study Period | 2019 - 2030 |
2024 Market Size | USD 3009.8 Million |
2030 Forecast | USD 3882.1 Million |
Growth Rate (CAGR) | 4.3% |
Largest Region | Europe |
Fastest Growing Region | Asia-Pacific |
Nature of the Market | Fragmented |
Report Code: 12521
Get a Comprehensive Overview of the Stoma Care Market Report Prepared by P&S Intelligence, Segmented by End User (Hospitals and Specialty Clinics, Ambulatory Surgery Centers, Homecare Settings), Surgery Type (Colostomy, Ileostomy, Urostomy), Product (Bags, Accessories), and Geographic Regions. This Report Provides Insights From 2019 to 2030.
Study Period | 2019 - 2030 |
2024 Market Size | USD 3009.8 Million |
2030 Forecast | USD 3882.1 Million |
Growth Rate (CAGR) | 4.3% |
Largest Region | Europe |
Fastest Growing Region | Asia-Pacific |
Nature of the Market | Fragmented |
Explore the market potential with our data-driven report
The stoma care market size stood at USD 3009.8 million in 2024, and it is expected to grow at a CAGR of 4.3% during 2024–2030, to reach USD 3,882.1 million by 2030. This is mainly attributed to the rising target population of patients suffering from inflammatory bowel disorders and colorectal and bladder cancers, the growing elderly population, the increasing number of stoma and ostomy surgeries of the intestine, technological improvements, and attractive reimbursement systems in developed nations.
Furthermore, the market will expand significantly due to the development of new products related to ostomy care, the rising demand for home healthcare services, and the increasing number of awareness programs to educate patients regarding the application of ostomy products.
Moreover, key players are playing a major role in improving stoma care by developing innovative technologies for minimizing skin infections. Hydrocolloids and innovative systems are manufactured for reducing the risk of skin irritation. For instance, in January 2020, Convatec Group plc announced the launch of ConvaMax, which is a new superabsorber dressing. This is an ideal superabsorber wound dressing that manages excess moisture to help protect skin integrity, where there is a real risk of skin damage due to high levels of exudate. ConvaMax has been extensively utilized for the management of highly exuding wounds, such as pressure ulcers, leg ulcers, dehisced surgical wounds, and diabetic foot ulcers.
Due to these technological advancements, companies are winning large-sized contracts, which are helping them generate significant revenue in the market. For instance, in June 2022, Hollister Incorporated won a new contract to supply its ostomy care products to all American Medical Association member hospitals and health systems across the U.S. Similarly, in March 2021, ConvaTec awarded a contract for ostomy products with Vizient Inc, a healthcare performance improvement company in the U.S. Vizient member facilities serve a large number of healthcare facilities, which perform a significant number of ostomy procedures in the U.S. each year.
Surging Prevalence of Inflammatory Conditions Drives the Industry
The rising prevalence of various inflammatory bowel conditions, such as Crohn’s disease or ulcerative colitis, diverticular disease, fecal incontinence, and colorectal and intestinal cancer, along with the growing healthcare expenditure, and the advent of novel products for stoma care are fueling the growth of the market.
For instance, as per a report published in May 2022, by the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA), approximately 10 million people globally are having inflammatory bowel disorders (IBD). Also, according to the same source, in the U.K., an estimated 0.81% of adults are living with IBD. Such a rise in the number of the population having IBDs is increasing multiple awareness programs of how the disorders are affecting the growing geriatric population.
Likewise, as per the American Cancer Society, in the U.S., colorectal cancer is the third most common cancer diagnosed and there were approximately 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer in 2022. Moreover, age raises the risk of colorectal cancer since it is often detected in patients between the ages of 65 and 74 years. This, in turn, is driving the growth of the stoma care sector.
The ostomy bags category is expected to witness a CAGR of around 6% during the forecast timeline. This can be ascribed to the escalation of temporary as well as permanent stoma surgeries among people suffering from IBDs and small and large intestine cancers, and technological advancements in this type of bag, which is required for stoma surgeries. For instance, in June 2021, Welland Medical Limited announced the launch of its brand-new ostomy pouch range Aurum Plus. This novel range of pouches is available in drainable, closed, and urostomy in various sizes. Through extensive research and development, Aurum Plus commenced as an ideal to give ostomates greater comfort, choice, and confidence.
Moreover, constant improvements made in available products as per the requirement of patients by major players and the advent of effective and appropriate pouching systems and related accessories that serve to enhance the quality of life of ostomy patients are projected to drive the market of stoma care over the forecast period. For instance, Trio Healthcare Ltd. launched Trio Siltac, which is the only silicone-based ostomy seal available globally. This seal provides a superior solution for averting leakage and protecting the skin around the base of the stoma.
In the surgery type segmentation, colostomy surgery is dominating the market. This is primarily due to the rising incidence of colon cancer and the increasing number of colostomy procedures. For instance, according to the United Ostomy Associations of America, approximately 100,000 ostomy surgeries are carried out in the U.S. every year. Common disorders leading to the need for colostomy surgeries include diverticulitis causing rupture, IBD, birth defect cancer, and bowel obstruction injury. In addition to that, the availability of various kinds of colostomy bags, such as drainable or closed system bags, is leading to the market growth in this category.
The hospitals and specialty clinics category dominate the market. This is because a large number of patients prefer to visit hospitals and specialty clinics in case of any pain or inflammatory disorders and the upgradation of healthcare infrastructure by governments and private players. In addition to that, the rising number of these facilities, the growing adoption of advanced technologies by small & large specialty clinics and hospitals, and the increasing launches of advanced technologies are fueling the market growth in this category.
Also, specialty clinics are emerging across the world, owing to a considerable rise in the number of outpatient ostomy clinics and stoma care nurses, offering support and educational services to ostomates.
On the other hand, the home care settings category is projected to witness the fastest growth during 2022–2030. This can be due to the surging adoption of home care services and the rising penetration of stoma care nursing interventions in these settings.
Drive strategic growth with comprehensive market analysis
In 2022, Europe accounted for the largest revenue share, of around 40%, and it is predicted to maintain its position during the forecast period as well. This is attributed to the surging incidence of inflammatory bowel diseases, robust healthcare infrastructure, the presence of leading industry players and reimbursement policies for stoma care surgeries by private insurance companies, and the growing government expenditure in the region.
Moreover, Germany is contributing the major revenue to the European market. This is owing to the surging need for ostomy pouches, accessories, and services at a high pace. Apart from this, the rising disposable income of people in the country is creating a high demand for stoma surgeries.
In Europe, France is having the best healthcare system along with excellent services in public healthcare in the world. The healthcare system is equipped with the best infrastructure and advanced facilities, along with a fully integrated network of public and private hospitals, doctors, and other medical service providers. Also, the incidence of bladder cancer, the geriatric population, the consumption of tobacco, and the awareness associated with ostomy care among patients with stomas are increasing in France. Hence, these factors drive the French market growth.
In addition, the cases of bladder cancer are rising in France, due to the increasing prevalence of urinary tract cancer, which occurs mostly in women. The incidence rates of bladder and kidney cancers among men and women in the country are 1:3 and 1:6, respectively. This is due to the increase in the adoption of unhealthy lifestyles and a lack of knowledge. Thus, these factors boost the demand for stoma care.
On the other hand, the APAC market is projected to witness the fastest growth in the coming years. This can be due to huge patient bases in countries like China and India, various government initiatives, and the growing medical industry offering advanced stoma care facilities in the region.
This fully customizable report gives a detailed analysis of the stoma care industry from 2019 to 2030, based on all the relevant segments and geographies.
Based on End User
Based on Surgery Type
Based on Product
Geographical Analysis
The stoma care market size stood at USD 3009.8 million in 2024.
During 2024–2030, the growth rate of the stoma care market will be 4.3%.
Hospitals and specialty clinics is the largest end-user category in the stoma care market.
The major drivers of the stoma care market include the rising number of ostomy surgeries, the surging emphasis on the adoption of preventative maintenance practices among healthcare facilities, and the increasing number of patient awareness programs by non-profit organizations and various industry players on the usage of innovative ostomy products.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
IndiaOur insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages